Jianting Sheng
Overview
Explore the profile of Jianting Sheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
2006
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kermany D, Ahn J, Vasquez M, Zhang W, Wang L, Liu K, et al.
Cancer Commun (Lond)
. 2025 Jan;
PMID: 39749685
No abstract available.
2.
Dong W, Sheng J, Cui J, Zhao H, Wong S
Trends Immunol
. 2024 Oct;
45(11):903-916.
PMID: 39443266
Brain metastasis poses formidable clinical challenges due to its intricate interactions with the brain's unique immune environment, often resulting in poor prognoses. This review delves into systems immunology's role in...
3.
Ban Y, Zou Y, Liu Y, Lee S, Bednarczyk R, Sheng J, et al.
Elife
. 2024 Sep;
12.
PMID: 39259576
Epithelial-to-mesenchymal transition (EMT) contributes significantly to chemotherapy resistance and remains a critical challenge in treating advanced breast cancer. The complexity of EMT, involving redundant pro-EMT signaling pathways and its paradox...
4.
Niyakan S, Sheng J, Cao Y, Zhang X, Xu Z, Wu L, et al.
Patterns (N Y)
. 2024 May;
5(5):100986.
PMID: 38800365
Spatially resolved transcriptomics has revolutionized genome-scale transcriptomic profiling by providing high-resolution characterization of transcriptional patterns. Here, we present our spatial transcriptomics analysis framework, MUSTANG (MUlti-sample Spatial Transcriptomics data ANalysis with...
5.
Wang L, Dong W, Yin Z, Sheng J, Ezeana C, Yang L, et al.
bioRxiv
. 2024 Jan;
PMID: 38260351
Single cell lineage tracing, essential for unraveling cellular dynamics in disease evolution is critical for developing targeted therapies. CRISPR-Cas9, known for inducing permanent and cumulative mutations, is a cornerstone in...
6.
Ban Y, Zou Y, Liu Y, Lee S, Bednarczyk R, Sheng J, et al.
bioRxiv
. 2023 Jul;
PMID: 37425795
Significance: This study uncovers the crucial involvement of ribosome biogenesis (RiBi) in the regulation of epithelial and mesenchymal state oscillations in breast cancer cells, which plays a major role in...
7.
Ferri-Borgogno S, Zhu Y, Sheng J, Burks J, Gomez J, Wong K, et al.
Cancer Res
. 2023 Feb;
83(9):1503-1516.
PMID: 36787106
Significance: Generation of spatially resolved gene expression patterns in tumors from patients with ovarian cancer surviving more than 10 years allows the identification of novel predictive biomarkers and therapeutic targets...
8.
Ban Y, Markowitz G, Zou Y, Ramchandani D, Kraynak J, Sheng J, et al.
Nat Cancer
. 2022 Feb;
3(2):262.
PMID: 35122075
No abstract available.
9.
Ban Y, Markowitz G, Zou Y, Ramchandani D, Kraynak J, Sheng J, et al.
Nat Cancer
. 2021 Dec;
2(9):919-931.
PMID: 34917944
Radiation therapy (RT) in combination with immune checkpoint inhibitor (ICI) represents a promising regimen for non-small cell lung cancer (NSCLC), however, the underlying mechanisms are poorly characterized. We identified a...
10.
Zhu Y, Ferri-Borgogno S, Sheng J, Yeung T, Burks J, Cappello P, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33917869
Stromal and immune cells in the tumor microenvironment (TME) have been shown to directly affect high-grade serous ovarian cancer (HGSC) malignant phenotypes, however, how these cells interact to influence HGSC...